PD-L1 Copy Number Alterations as an Adjunct Biomarker of Response to Immunotherapy in Advanced NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Thoracic Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Programmed Death-Ligand 1 Copy Number Alteration as an Adjunct Biomarker of Response to Immunotherapy in Advanced Non-small Cell Lung Cancer
J Thorac Oncol 2023 Apr 05;[EPub Ahead of Print], TH Hong, YH Bang, C Joe, S Hwang, B Lee, N Lee, S Park, HA Jung, JM Sun, JS Ahn, MJ Ahn, YL Choi, SH LeeFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.